Pfizer and Morgan State University have partnered together to offer a fellowship in vaccine medical development that will be available to students in Morgan State’s Doctor of Public Health Program. The Program is fully funded by Prizer, over $335,000 for the two-year fellowship, and is both the first doctoral fellowship program and first fellowship program at a historically Black college or university for the company.
Kim Dobson Snyder, dean of Morgan’s School of Community Health and Policy, expressed how the COVID-19 pandemic emphasized health disparities across race, class, and gender, and highlighted the necessity for diversity in public health and medical fields.
“There has been a longstanding, in public health, perspective that diversity is good for the health and well-being of individuals,” she said, adding that increasing diversity within the field of vaccine development, specifically, is important for creating “that trust and credibility that gets built knowing that diverse individuals were involved.”
Monica Ochapa and Nguhemen Tingir were selected among Morgan University’s DrPH candidates as the inaugural fellows and will begin the program in August.
For more information, please visit the article below.
The Daily Record
Morgan State University Press Release
